KUR-024

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKUR-024
Drug Alias NameKUR-024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone synthesis stimulants
TargetsUpdating
Therapy Area/IndicationsFractures, Bone
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKuros Biosurgery Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKuros Biosurgery Ag
Active IndicationsN/A
Inactive IndicationsFractures, Bone

Other Information

ATC CodeN/A
Related LinksN/A